Drug Type Small molecule drug |
Synonyms |
Action inhibitors |
Mechanism Ubiquitin ligase inhibitors(E3 ubiquitin ligase components inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | Israel | - | |
Neoplasms | Discovery | Israel | - | |
Neoplasms | Discovery | Israel | - |